Dr. Brett Gourley, MD
Claim this profileMultiCare Health System Institute for Research and Innovation
Studies Leukemia
Studies Lymphoma
6 reported clinical trials
15 drugs studied
Area of expertise
1Leukemia
t(8;21) negative
inv(16) negative
t(16;16) negative
2Lymphoma
EZH2 positive
CNG positive
CNG negative
Affiliated Hospitals
Clinical Trials Brett Gourley, MD is currently running
Pirtobrutinib + VR
for Chronic Lymphocytic Leukemia
The purpose of this study is to compare the efficacy and safety of fixed duration pirtobruitinib (LOXO-305) with VR (Arm A) compared to VR alone (Arm B) in patients with CLL/SLL who have been previously treated with at least one prior line of therapy. Participation could last up to five years.
Recruiting2 awards Phase 3
Tazemetostat + Lenalidomide + Rituximab
for Follicular Lymphoma
The participants of this study would have relapsed/refractory follicular lymphoma. Follicular lymphoma is a type of blood cancer. It is referred to as 'relapsed' when the disease has come back after a period of improvement after that follows a treatment regimen and 'refractory' when treatment no longer works. Stage 1 of this trial will study the safety and the level that adverse effects of each of the study drug combinations can be tolerated (known as tolerability). It is also designed to establish a recommended study drug dosage for stage 2 and 3. Stage 1 of the study is completed. Stages 2 and 3 will evaluate and compare how long participants live without their disease getting worse when receiving the study drug in combination with other drug treatment versus the placebo (dummy drug) in combination with other drug treatment.
Recruiting1 award Phase 34 criteria
More about Brett Gourley, MD
Clinical Trial Related4 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Brett Gourley, MD has experience with
- Rituximab
- Pirtobrutinib
- Tazemetostat
- Lenalidomide
- Gilteritinib
- Midostaurin
Breakdown of trials Brett Gourley, MD has run
Leukemia
Lymphoma
Myeloid Leukemia
Acute Myeloid Leukemia
Chronic Lymphocytic Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Brett Gourley, MD specialize in?
Brett Gourley, MD focuses on Leukemia and Lymphoma. In particular, much of their work with Leukemia has involved t(8;21) negative patients, or patients who are inv(16) negative.
Is Brett Gourley, MD currently recruiting for clinical trials?
Yes, Brett Gourley, MD is currently recruiting for 3 clinical trials in Spokane Washington. If you're interested in participating, you should apply.
Are there any treatments that Brett Gourley, MD has studied deeply?
Yes, Brett Gourley, MD has studied treatments such as Rituximab, Pirtobrutinib, Tazemetostat.
What is the best way to schedule an appointment with Brett Gourley, MD?
Apply for one of the trials that Brett Gourley, MD is conducting.
What is the office address of Brett Gourley, MD?
The office of Brett Gourley, MD is located at: MultiCare Health System Institute for Research and Innovation, Spokane, Washington 99218 United States. This is the address for their practice at the MultiCare Health System Institute for Research and Innovation.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.